LEADER 01280nam  2200349Ia 450 
001 9910699264003321
005 20230902161942.0
035   $a(CKB)5470000002401265
035   $a(OCoLC)475058594
035   $a(EXLCZ)995470000002401265
100   $a20091207d1996      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aStructure and content of clinical study reports$b[electronic resource]
210  1$a[Rockville, Md] :$c[U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research],$d[1996]
215   $a1 online resource (various pagings) $cforms, charts
225 1 $aGuideline for industry ;$vICH E3
300   $a"July 1996."
410  0$aGuideline for industry ;$vICH E3.
606   $aClinical trials$xReporting$xGovernment policy$zUnited States
615  0$aClinical trials$xReporting$xGovernment policy
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 12$aInternational Conference on Harmonisation.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699264003321
996   $aStructure and content of clinical study reports$93151662
997   $aUNINA